GDNF-102 Clinical Study

Open-Label Safety Study of Glial Cell Line-Derived Neurotrophic Factor Gene Transfer (AAV2- GDNF) in Parkinson's Disease

GDNF-102 Clinical Study

Principal Investigator: Paul Larson, MD

Co-Principal Investigator: Chad Christine, MD

Contact: 

Aaron Daley, MS

415-476-9276

[email protected]

Marin Thompson, MS., CCRP.

415-353-9666

[email protected]

 

https://clinicaltrials.gov/ct2/show/NCT04167540